Sponsor:
Women and Infants Hospital of Rhode Island
Code:
NCT05806164
Conditions
Urgency Urinary Incontinence
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Accepted
Interventions
Beta3-Agonists, Adrenergic [Mirabegron/Vibegron]
OnabotulinumtoxinA 100 UNT [Botox]
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by Women and Infants Hospital of Rhode Island on 2025-09-25.